We are live on ! Find out more
ALIM

Alimera Sciences
ALIM

Delisted

ALIM was delisted on the 13th of September, 2024.

Back to rankings

38 hedge funds and large institutions have $35.7M invested in Alimera Sciences in 2017 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 7 increasing their positions, 13 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

3% less funds holding

Funds holding: 39 → 38 (-1)

10% less capital invested

Capital invested by funds: $39.6M → $35.7M (-$3.9M)

14% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 7

46% less repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 13

Holders
38
Holders Change
-1
Holders Change %
-2.56%
% of All Funds
0.95%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
7
Reduced
13
Closed
7
Calls
$15K
Puts
–
Net Calls
+$15K
Net Calls Change
+$15K

Top Buyers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
+$2.09M
2
JAM
JW Asset Management
Florida
+$186K
3
ACA
Avoro Capital Advisors
New York
+$143K
4
ARTA
A.R.T. Advisors
New York
+$119K
5
Renaissance Technologies
Renaissance Technologies
New York
+$95.6K

Top Sellers

Rank Fund Capital Flow
1
SCM
Stonepine Capital Management
Oregon
-$3.42M
2
DM
Deerfield Management
New York
-$1.58M
3
KCM
Kennedy Capital Management
Missouri
-$467K
4
BCM
Bridgeway Capital Management
Texas
-$335K
5
Vanguard Group
Vanguard Group
Pennsylvania
-$329K
Name Holding Trade Value Shares
Change 		Change in
Stake
ICOA
26
Investment Centers of America
North Dakota
$33K – – –
Millennium Management
27
Millennium Management
New York
$31K +$31.7K +1,480 New
GC
28
Guggenheim Capital
Illinois
$26K – – –
JP Morgan Chase
29
JP Morgan Chase
New York
$20K +$20.1K +940 New
AIM
30
Acrospire Investment Management
Illinois
$15K -$33.4K -1,557 -69%
SRC
31
Shufro Rose & Co
New York
$14K – – –
Deutsche Bank
32
Deutsche Bank
Germany
$11K +$12K +559 +4,300%
Manulife (Manufacturers Life Insurance)
33
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$3K -$21 -1 -0.6%
PCM
34
Prelude Capital Management
New York
$3K +$86 +4 +3%
Morgan Stanley
35
Morgan Stanley
New York
$1K -$2.85K -133 -83%
Bank of Montreal
36
Bank of Montreal
Ontario, Canada
$1K – – –
LTFS
37
Ladenburg Thalmann Financial Services
Florida
$1K – – –
BNP Paribas Financial Markets
38
BNP Paribas Financial Markets
France
$7 – – –
KCM
39
Kennedy Capital Management
Missouri
– -$467K -22,217 Closed
Wolverine Trading
40
Wolverine Trading
Illinois
– -$25.5K -1,188 Closed
CG
41
Cutler Group
California
– -$17K -846 Closed
TRCT
42
Tower Research Capital (TRC)
New York
– -$5K -229 Closed
Group One Trading
43
Group One Trading
Illinois
– -$4K -211 Closed
UBS Group
44
UBS Group
Switzerland
– -$4K -187 Closed
1
2

ALIM Hedge Fund Activity: Q2 2017 in Review

38 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Alimera Sciences (ALIM) for Q2 2017, worth a combined $35.7M — down 9.9% from $39.6M a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of ALIM and 6 opened new positions — a net loss of 1 holder — while 13 trimmed existing stakes and 7 added.

The largest buyer was Armistice Capital, adding an estimated $2.09M. The largest seller was Stonepine Capital Management, cutting an estimated $3.42M.

  • 38 institutional investors held Alimera Sciences (ALIM) as of Q2 2017, down from 39 in Q1 2017.
  • Funds reported $35.7M of Alimera Sciences stock for Q2 2017, down 9.9% quarter-over-quarter.
  • 6 funds opened new Alimera Sciences positions in Q2 2017 and 7 closed out, a net change of -1 holder.
  • The largest Alimera Sciences buyer in Q2 2017 was Armistice Capital, an estimated $2.09M added.
  • The largest Alimera Sciences seller in Q2 2017 was Stonepine Capital Management, an estimated $3.42M sold.

Based on aggregated 13F filings for Q2 2017.